nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCC10—Vincristine—sarcoma	0.0581	0.0862	CbGbCtD
Cyclosporine—ABCC10—Etoposide—sarcoma	0.0532	0.079	CbGbCtD
Cyclosporine—ABCC3—Vincristine—sarcoma	0.0365	0.0542	CbGbCtD
Cyclosporine—ABCC1—Dactinomycin—sarcoma	0.0364	0.0541	CbGbCtD
Cyclosporine—ABCC10—Doxorubicin—sarcoma	0.0363	0.0539	CbGbCtD
Cyclosporine—ABCC3—Etoposide—sarcoma	0.0335	0.0497	CbGbCtD
Cyclosporine—ABCC1—Mitoxantrone—sarcoma	0.0326	0.0484	CbGbCtD
Cyclosporine—ABCB11—Vincristine—sarcoma	0.0316	0.0469	CbGbCtD
Cyclosporine—ABCC1—Epirubicin—sarcoma	0.0264	0.0392	CbGbCtD
Cyclosporine—ABCG2—Dactinomycin—sarcoma	0.0244	0.0362	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—sarcoma	0.0228	0.0339	CbGbCtD
Cyclosporine—ABCC1—Vincristine—sarcoma	0.0224	0.0333	CbGbCtD
Cyclosporine—ABCG2—Mitoxantrone—sarcoma	0.0218	0.0324	CbGbCtD
Cyclosporine—ABCC1—Etoposide—sarcoma	0.0206	0.0305	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—sarcoma	0.0197	0.0293	CbGbCtD
Cyclosporine—ABCC2—Vincristine—sarcoma	0.0166	0.0246	CbGbCtD
Cyclosporine—ABCC2—Etoposide—sarcoma	0.0152	0.0226	CbGbCtD
Cyclosporine—ABCG2—Vincristine—sarcoma	0.015	0.0223	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—sarcoma	0.014	0.0208	CbGbCtD
Cyclosporine—ABCG2—Etoposide—sarcoma	0.0138	0.0204	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0111	0.0165	CbGbCtD
Cyclosporine—CYP3A7—Vincristine—sarcoma	0.0111	0.0165	CbGbCtD
Cyclosporine—CYP3A4—Thiotepa—sarcoma	0.011	0.0163	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—sarcoma	0.0104	0.0154	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—sarcoma	0.00938	0.0139	CbGbCtD
Cyclosporine—ABCB1—Dactinomycin—sarcoma	0.00879	0.013	CbGbCtD
Cyclosporine—CYP3A5—Vincristine—sarcoma	0.00832	0.0123	CbGbCtD
Cyclosporine—ABCB1—Mitoxantrone—sarcoma	0.00786	0.0117	CbGbCtD
Cyclosporine—CYP3A5—Etoposide—sarcoma	0.00762	0.0113	CbGbCtD
Cyclosporine—CYP2C8—Etoposide—sarcoma	0.00733	0.0109	CbGbCtD
Cyclosporine—ABCB1—Vincristine—sarcoma	0.00541	0.00804	CbGbCtD
Cyclosporine—ABCB1—Etoposide—sarcoma	0.00496	0.00736	CbGbCtD
Cyclosporine—CYP3A4—Mitoxantrone—sarcoma	0.00471	0.007	CbGbCtD
Cyclosporine—ABCB1—Doxorubicin—sarcoma	0.00338	0.00502	CbGbCtD
Cyclosporine—CYP3A4—Vincristine—sarcoma	0.00324	0.00481	CbGbCtD
Cyclosporine—CYP2D6—Doxorubicin—sarcoma	0.00319	0.00473	CbGbCtD
Cyclosporine—CYP3A4—Etoposide—sarcoma	0.00297	0.00441	CbGbCtD
Cyclosporine—FKBP4—mammary gland—sarcoma	0.00205	0.022	CbGeAlD
Cyclosporine—CYP3A4—Doxorubicin—sarcoma	0.00203	0.00301	CbGbCtD
Cyclosporine—PPP3R2—testis—sarcoma	0.00181	0.0193	CbGeAlD
Cyclosporine—PPIA—mammary gland—sarcoma	0.0017	0.0182	CbGeAlD
Cyclosporine—FKBP4—embryo—sarcoma	0.0014	0.015	CbGeAlD
Cyclosporine—PPIF—mammary gland—sarcoma	0.00138	0.0148	CbGeAlD
Cyclosporine—PPID—myometrium—sarcoma	0.00135	0.0144	CbGeAlD
Cyclosporine—CAMLG—myometrium—sarcoma	0.00133	0.0142	CbGeAlD
Cyclosporine—PPP3CA—mammary gland—sarcoma	0.00132	0.0141	CbGeAlD
Cyclosporine—SLC10A2—hematopoietic system—sarcoma	0.00126	0.0135	CbGeAlD
Cyclosporine—FKBP4—hematopoietic system—sarcoma	0.00125	0.0134	CbGeAlD
Cyclosporine—PPID—seminal vesicle—sarcoma	0.00122	0.013	CbGeAlD
Cyclosporine—PPIA—myometrium—sarcoma	0.00121	0.0129	CbGeAlD
Cyclosporine—FKBP4—connective tissue—sarcoma	0.00121	0.0129	CbGeAlD
Cyclosporine—CAMLG—seminal vesicle—sarcoma	0.0012	0.0128	CbGeAlD
Cyclosporine—PPID—hematopoietic system—sarcoma	0.00116	0.0124	CbGeAlD
Cyclosporine—CAMLG—hematopoietic system—sarcoma	0.00114	0.0122	CbGeAlD
Cyclosporine—FKBP4—skin of body—sarcoma	0.00109	0.0116	CbGeAlD
Cyclosporine—FKBP1B—testis—sarcoma	0.00104	0.0111	CbGeAlD
Cyclosporine—PPID—smooth muscle tissue—sarcoma	0.00102	0.0109	CbGeAlD
Cyclosporine—FKBP1B—liver—sarcoma	0.000981	0.0105	CbGeAlD
Cyclosporine—PPIF—myometrium—sarcoma	0.000978	0.0105	CbGeAlD
Cyclosporine—FKBP4—uterus—sarcoma	0.000946	0.0101	CbGeAlD
Cyclosporine—PPP3CA—myometrium—sarcoma	0.000937	0.01	CbGeAlD
Cyclosporine—PPIB—myometrium—sarcoma	0.000931	0.00997	CbGeAlD
Cyclosporine—PPIF—seminal vesicle—sarcoma	0.000884	0.00946	CbGeAlD
Cyclosporine—FKBP4—lymphoid tissue—sarcoma	0.000881	0.00943	CbGeAlD
Cyclosporine—PPID—cardiac atrium—sarcoma	0.000877	0.00939	CbGeAlD
Cyclosporine—FKBP1A—mammary gland—sarcoma	0.000877	0.00939	CbGeAlD
Cyclosporine—CAMLG—cardiac atrium—sarcoma	0.000865	0.00925	CbGeAlD
Cyclosporine—CAMLG—uterus—sarcoma	0.00086	0.00921	CbGeAlD
Cyclosporine—PPP3CA—seminal vesicle—sarcoma	0.000846	0.00906	CbGeAlD
Cyclosporine—PPIB—seminal vesicle—sarcoma	0.000841	0.009	CbGeAlD
Cyclosporine—PPIF—hematopoietic system—sarcoma	0.00084	0.00899	CbGeAlD
Cyclosporine—FKBP4—tendon—sarcoma	0.000828	0.00887	CbGeAlD
Cyclosporine—PPP3CA—hematopoietic system—sarcoma	0.000804	0.00861	CbGeAlD
Cyclosporine—CAMLG—lymphoid tissue—sarcoma	0.000802	0.00858	CbGeAlD
Cyclosporine—PPIB—hematopoietic system—sarcoma	0.0008	0.00856	CbGeAlD
Cyclosporine—PPIA—uterus—sarcoma	0.000783	0.00838	CbGeAlD
Cyclosporine—PPP3CA—connective tissue—sarcoma	0.000774	0.00829	CbGeAlD
Cyclosporine—PPIB—connective tissue—sarcoma	0.00077	0.00824	CbGeAlD
Cyclosporine—PPID—tendon—sarcoma	0.000765	0.00818	CbGeAlD
Cyclosporine—CAMLG—tendon—sarcoma	0.000754	0.00807	CbGeAlD
Cyclosporine—FKBP1B—lymph node—sarcoma	0.000752	0.00805	CbGeAlD
Cyclosporine—SLCO1B1—mammary gland—sarcoma	0.000744	0.00796	CbGeAlD
Cyclosporine—PPID—bone marrow—sarcoma	0.000741	0.00793	CbGeAlD
Cyclosporine—PPIF—smooth muscle tissue—sarcoma	0.00074	0.00792	CbGeAlD
Cyclosporine—PPIF—skin of body—sarcoma	0.00073	0.00782	CbGeAlD
Cyclosporine—CAMLG—bone marrow—sarcoma	0.00073	0.00781	CbGeAlD
Cyclosporine—SLC10A1—seminal vesicle—sarcoma	0.00072	0.0077	CbGeAlD
Cyclosporine—PPP3CA—smooth muscle tissue—sarcoma	0.000708	0.00758	CbGeAlD
Cyclosporine—PPIB—smooth muscle tissue—sarcoma	0.000704	0.00754	CbGeAlD
Cyclosporine—PPIB—skin of body—sarcoma	0.000695	0.00744	CbGeAlD
Cyclosporine—PPIA—tendon—sarcoma	0.000686	0.00735	CbGeAlD
Cyclosporine—FKBP4—testis—sarcoma	0.000686	0.00734	CbGeAlD
Cyclosporine—PPIA—bone marrow—sarcoma	0.000665	0.00712	CbGeAlD
Cyclosporine—FKBP4—liver—sarcoma	0.000649	0.00694	CbGeAlD
Cyclosporine—PPIF—cardiac atrium—sarcoma	0.000638	0.00683	CbGeAlD
Cyclosporine—PPIF—uterus—sarcoma	0.000634	0.00679	CbGeAlD
Cyclosporine—PPID—testis—sarcoma	0.000633	0.00677	CbGeAlD
Cyclosporine—CAMLG—testis—sarcoma	0.000624	0.00668	CbGeAlD
Cyclosporine—FKBP1A—myometrium—sarcoma	0.000622	0.00666	CbGeAlD
Cyclosporine—PPP3CA—cardiac atrium—sarcoma	0.000611	0.00654	CbGeAlD
Cyclosporine—PPP3CA—uterus—sarcoma	0.000608	0.0065	CbGeAlD
Cyclosporine—PPIB—cardiac atrium—sarcoma	0.000607	0.0065	CbGeAlD
Cyclosporine—PPIB—uterus—sarcoma	0.000604	0.00646	CbGeAlD
Cyclosporine—PPID—liver—sarcoma	0.000599	0.0064	CbGeAlD
Cyclosporine—CAMLG—liver—sarcoma	0.00059	0.00631	CbGeAlD
Cyclosporine—PPIA—testis—sarcoma	0.000568	0.00608	CbGeAlD
Cyclosporine—PPP3CA—lymphoid tissue—sarcoma	0.000566	0.00606	CbGeAlD
Cyclosporine—PPIB—lymphoid tissue—sarcoma	0.000563	0.00602	CbGeAlD
Cyclosporine—FKBP1A—seminal vesicle—sarcoma	0.000562	0.00602	CbGeAlD
Cyclosporine—PPIF—tendon—sarcoma	0.000556	0.00595	CbGeAlD
Cyclosporine—PPIF—bone marrow—sarcoma	0.000538	0.00576	CbGeAlD
Cyclosporine—PPIA—liver—sarcoma	0.000537	0.00575	CbGeAlD
Cyclosporine—FKBP1A—hematopoietic system—sarcoma	0.000534	0.00572	CbGeAlD
Cyclosporine—PPP3CA—tendon—sarcoma	0.000532	0.0057	CbGeAlD
Cyclosporine—PPIB—tendon—sarcoma	0.000529	0.00566	CbGeAlD
Cyclosporine—PPP3CA—bone marrow—sarcoma	0.000516	0.00552	CbGeAlD
Cyclosporine—FKBP1A—connective tissue—sarcoma	0.000514	0.00551	CbGeAlD
Cyclosporine—PPIB—bone marrow—sarcoma	0.000513	0.00549	CbGeAlD
Cyclosporine—ABCC10—myometrium—sarcoma	0.000499	0.00534	CbGeAlD
Cyclosporine—FKBP4—lymph node—sarcoma	0.000497	0.00532	CbGeAlD
Cyclosporine—FKBP1A—smooth muscle tissue—sarcoma	0.000471	0.00504	CbGeAlD
Cyclosporine—FKBP1A—skin of body—sarcoma	0.000465	0.00497	CbGeAlD
Cyclosporine—PPIF—testis—sarcoma	0.00046	0.00493	CbGeAlD
Cyclosporine—PPID—lymph node—sarcoma	0.000459	0.00491	CbGeAlD
Cyclosporine—SLCO1B1—hematopoietic system—sarcoma	0.000453	0.00485	CbGeAlD
Cyclosporine—CAMLG—lymph node—sarcoma	0.000452	0.00484	CbGeAlD
Cyclosporine—ABCC10—seminal vesicle—sarcoma	0.00045	0.00482	CbGeAlD
Cyclosporine—PPP3CA—testis—sarcoma	0.000441	0.00472	CbGeAlD
Cyclosporine—PPIB—testis—sarcoma	0.000438	0.00469	CbGeAlD
Cyclosporine—PPIF—liver—sarcoma	0.000435	0.00466	CbGeAlD
Cyclosporine—ABCC3—hematopoietic system—sarcoma	0.00043	0.0046	CbGeAlD
Cyclosporine—ABCC10—hematopoietic system—sarcoma	0.000428	0.00458	CbGeAlD
Cyclosporine—CYP2C8—mammary gland—sarcoma	0.000423	0.00453	CbGeAlD
Cyclosporine—PPP3CA—liver—sarcoma	0.000417	0.00446	CbGeAlD
Cyclosporine—PPIB—liver—sarcoma	0.000414	0.00443	CbGeAlD
Cyclosporine—PPIA—lymph node—sarcoma	0.000412	0.00441	CbGeAlD
Cyclosporine—FKBP1A—cardiac atrium—sarcoma	0.000406	0.00434	CbGeAlD
Cyclosporine—FKBP1A—uterus—sarcoma	0.000404	0.00432	CbGeAlD
Cyclosporine—FKBP1A—lymphoid tissue—sarcoma	0.000376	0.00403	CbGeAlD
Cyclosporine—CYP2C9—mammary gland—sarcoma	0.000376	0.00402	CbGeAlD
Cyclosporine—SLC10A1—testis—sarcoma	0.000375	0.00401	CbGeAlD
Cyclosporine—ABCB11—testis—sarcoma	0.00037	0.00396	CbGeAlD
Cyclosporine—SLCO1A2—hematopoietic system—sarcoma	0.000369	0.00395	CbGeAlD
Cyclosporine—SLC10A1—liver—sarcoma	0.000354	0.00379	CbGeAlD
Cyclosporine—FKBP1A—tendon—sarcoma	0.000354	0.00378	CbGeAlD
Cyclosporine—ABCC1—myometrium—sarcoma	0.000353	0.00377	CbGeAlD
Cyclosporine—ABCB11—liver—sarcoma	0.00035	0.00375	CbGeAlD
Cyclosporine—FKBP1A—bone marrow—sarcoma	0.000343	0.00367	CbGeAlD
Cyclosporine—CYP3A7—liver—sarcoma	0.000343	0.00367	CbGeAlD
Cyclosporine—PPIF—lymph node—sarcoma	0.000334	0.00357	CbGeAlD
Cyclosporine—ABCC10—cardiac atrium—sarcoma	0.000325	0.00348	CbGeAlD
Cyclosporine—ABCC10—uterus—sarcoma	0.000323	0.00346	CbGeAlD
Cyclosporine—PPP3CA—lymph node—sarcoma	0.000319	0.00342	CbGeAlD
Cyclosporine—ABCC1—seminal vesicle—sarcoma	0.000319	0.00341	CbGeAlD
Cyclosporine—PPIB—lymph node—sarcoma	0.000318	0.0034	CbGeAlD
Cyclosporine—ABCC10—lymphoid tissue—sarcoma	0.000301	0.00323	CbGeAlD
Cyclosporine—CYP2C19—hematopoietic system—sarcoma	0.000295	0.00316	CbGeAlD
Cyclosporine—FKBP1A—testis—sarcoma	0.000293	0.00313	CbGeAlD
Cyclosporine—ABCG2—myometrium—sarcoma	0.000292	0.00312	CbGeAlD
Cyclosporine—CYP3A7-CYP3A51P—liver—sarcoma	0.000291	0.00312	CbGeAlD
Cyclosporine—ABCC10—tendon—sarcoma	0.000283	0.00303	CbGeAlD
Cyclosporine—FKBP1A—liver—sarcoma	0.000277	0.00296	CbGeAlD
Cyclosporine—ABCC10—bone marrow—sarcoma	0.000274	0.00294	CbGeAlD
Cyclosporine—ABCG2—seminal vesicle—sarcoma	0.000264	0.00282	CbGeAlD
Cyclosporine—CYP2C8—hematopoietic system—sarcoma	0.000258	0.00276	CbGeAlD
Cyclosporine—ABCC3—testis—sarcoma	0.000236	0.00252	CbGeAlD
Cyclosporine—SLCO1B1—liver—sarcoma	0.000235	0.00251	CbGeAlD
Cyclosporine—ABCC10—testis—sarcoma	0.000235	0.00251	CbGeAlD
Cyclosporine—CYP3A5—hematopoietic system—sarcoma	0.000233	0.00249	CbGeAlD
Cyclosporine—ABCC1—cardiac atrium—sarcoma	0.00023	0.00246	CbGeAlD
Cyclosporine—CYP2C9—hematopoietic system—sarcoma	0.000229	0.00245	CbGeAlD
Cyclosporine—ABCC1—uterus—sarcoma	0.000229	0.00245	CbGeAlD
Cyclosporine—ABCC2—tendon—sarcoma	0.000227	0.00243	CbGeAlD
Cyclosporine—ABCC3—liver—sarcoma	0.000223	0.00239	CbGeAlD
Cyclosporine—ABCC10—liver—sarcoma	0.000222	0.00237	CbGeAlD
Cyclosporine—FKBP1A—lymph node—sarcoma	0.000212	0.00227	CbGeAlD
Cyclosporine—SLCO1A2—testis—sarcoma	0.000202	0.00216	CbGeAlD
Cyclosporine—ABCC1—tendon—sarcoma	0.0002	0.00214	CbGeAlD
Cyclosporine—SLCO1A2—liver—sarcoma	0.000191	0.00205	CbGeAlD
Cyclosporine—ABCG2—uterus—sarcoma	0.000189	0.00203	CbGeAlD
Cyclosporine—ABCC2—testis—sarcoma	0.000188	0.00202	CbGeAlD
Cyclosporine—ABCC2—liver—sarcoma	0.000178	0.00191	CbGeAlD
Cyclosporine—CYP3A4—hematopoietic system—sarcoma	0.000175	0.00187	CbGeAlD
Cyclosporine—CYP2D6—hematopoietic system—sarcoma	0.000172	0.00184	CbGeAlD
Cyclosporine—ABCC3—lymph node—sarcoma	0.000171	0.00183	CbGeAlD
Cyclosporine—ABCC10—lymph node—sarcoma	0.00017	0.00182	CbGeAlD
Cyclosporine—ABCC1—testis—sarcoma	0.000166	0.00178	CbGeAlD
Cyclosporine—ABCG2—bone marrow—sarcoma	0.000161	0.00172	CbGeAlD
Cyclosporine—ABCC1—liver—sarcoma	0.000157	0.00168	CbGeAlD
Cyclosporine—CYP2C19—liver—sarcoma	0.000153	0.00164	CbGeAlD
Cyclosporine—ABCB1—myometrium—sarcoma	0.000144	0.00154	CbGeAlD
Cyclosporine—CYP2C8—testis—sarcoma	0.000141	0.00151	CbGeAlD
Cyclosporine—ABCB1—embryo—sarcoma	0.000138	0.00148	CbGeAlD
Cyclosporine—ABCG2—testis—sarcoma	0.000137	0.00147	CbGeAlD
Cyclosporine—ABCC2—lymph node—sarcoma	0.000137	0.00146	CbGeAlD
Cyclosporine—CYP2C8—liver—sarcoma	0.000134	0.00143	CbGeAlD
Cyclosporine—ABCB1—seminal vesicle—sarcoma	0.00013	0.00139	CbGeAlD
Cyclosporine—ABCG2—liver—sarcoma	0.00013	0.00139	CbGeAlD
Cyclosporine—ABCB1—hematopoietic system—sarcoma	0.000124	0.00132	CbGeAlD
Cyclosporine—CYP3A5—liver—sarcoma	0.000121	0.00129	CbGeAlD
Cyclosporine—ABCC1—lymph node—sarcoma	0.00012	0.00129	CbGeAlD
Cyclosporine—CYP2C9—liver—sarcoma	0.000119	0.00127	CbGeAlD
Cyclosporine—ABCG2—lymph node—sarcoma	9.96e-05	0.00107	CbGeAlD
Cyclosporine—Diarrhoea—Thiotepa—sarcoma	9.89e-05	0.000608	CcSEcCtD
Cyclosporine—Abdominal pain—Mitoxantrone—sarcoma	9.87e-05	0.000606	CcSEcCtD
Cyclosporine—Body temperature increased—Mitoxantrone—sarcoma	9.87e-05	0.000606	CcSEcCtD
Cyclosporine—Bronchitis—Epirubicin—sarcoma	9.84e-05	0.000605	CcSEcCtD
Cyclosporine—Diarrhoea—Dactinomycin—sarcoma	9.82e-05	0.000603	CcSEcCtD
Cyclosporine—Gastritis—Doxorubicin—sarcoma	9.7e-05	0.000596	CcSEcCtD
Cyclosporine—Muscular weakness—Doxorubicin—sarcoma	9.67e-05	0.000594	CcSEcCtD
Cyclosporine—Dysuria—Epirubicin—sarcoma	9.57e-05	0.000588	CcSEcCtD
Cyclosporine—Dizziness—Thiotepa—sarcoma	9.56e-05	0.000587	CcSEcCtD
Cyclosporine—Abdominal distension—Doxorubicin—sarcoma	9.54e-05	0.000586	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Epirubicin—sarcoma	9.51e-05	0.000585	CcSEcCtD
Cyclosporine—Dysphagia—Doxorubicin—sarcoma	9.47e-05	0.000582	CcSEcCtD
Cyclosporine—Pollakiuria—Epirubicin—sarcoma	9.46e-05	0.000581	CcSEcCtD
Cyclosporine—Hypersensitivity—Vincristine—sarcoma	9.45e-05	0.00058	CcSEcCtD
Cyclosporine—CYP2D6—testis—sarcoma	9.42e-05	0.00101	CbGeAlD
Cyclosporine—ABCB1—uterus—sarcoma	9.34e-05	0.000999	CbGeAlD
Cyclosporine—Paraesthesia—Etoposide—sarcoma	9.33e-05	0.000573	CcSEcCtD
Cyclosporine—Weight increased—Epirubicin—sarcoma	9.32e-05	0.000572	CcSEcCtD
Cyclosporine—Pancreatitis—Doxorubicin—sarcoma	9.29e-05	0.000571	CcSEcCtD
Cyclosporine—Weight decreased—Epirubicin—sarcoma	9.26e-05	0.000569	CcSEcCtD
Cyclosporine—Dyspnoea—Etoposide—sarcoma	9.26e-05	0.000569	CcSEcCtD
Cyclosporine—Hyperglycaemia—Epirubicin—sarcoma	9.23e-05	0.000567	CcSEcCtD
Cyclosporine—Somnolence—Etoposide—sarcoma	9.23e-05	0.000567	CcSEcCtD
Cyclosporine—Hypersensitivity—Mitoxantrone—sarcoma	9.2e-05	0.000565	CcSEcCtD
Cyclosporine—Asthenia—Vincristine—sarcoma	9.2e-05	0.000565	CcSEcCtD
Cyclosporine—Vomiting—Thiotepa—sarcoma	9.19e-05	0.000565	CcSEcCtD
Cyclosporine—Pneumonia—Epirubicin—sarcoma	9.18e-05	0.000564	CcSEcCtD
Cyclosporine—Infestation—Epirubicin—sarcoma	9.13e-05	0.000561	CcSEcCtD
Cyclosporine—Infestation NOS—Epirubicin—sarcoma	9.13e-05	0.000561	CcSEcCtD
Cyclosporine—Vomiting—Dactinomycin—sarcoma	9.12e-05	0.000561	CcSEcCtD
Cyclosporine—Rash—Thiotepa—sarcoma	9.12e-05	0.00056	CcSEcCtD
Cyclosporine—Bronchitis—Doxorubicin—sarcoma	9.11e-05	0.00056	CcSEcCtD
Cyclosporine—Dermatitis—Thiotepa—sarcoma	9.11e-05	0.00056	CcSEcCtD
Cyclosporine—Headache—Thiotepa—sarcoma	9.06e-05	0.000557	CcSEcCtD
Cyclosporine—Rash—Dactinomycin—sarcoma	9.05e-05	0.000556	CcSEcCtD
Cyclosporine—CYP3A4—liver—sarcoma	9.05e-05	0.000968	CbGeAlD
Cyclosporine—Decreased appetite—Etoposide—sarcoma	9.03e-05	0.000555	CcSEcCtD
Cyclosporine—Renal failure—Epirubicin—sarcoma	8.97e-05	0.000551	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Etoposide—sarcoma	8.97e-05	0.000551	CcSEcCtD
Cyclosporine—Asthenia—Mitoxantrone—sarcoma	8.96e-05	0.00055	CcSEcCtD
Cyclosporine—Fatigue—Etoposide—sarcoma	8.95e-05	0.00055	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Epirubicin—sarcoma	8.95e-05	0.00055	CcSEcCtD
Cyclosporine—CYP2D6—liver—sarcoma	8.9e-05	0.000953	CbGeAlD
Cyclosporine—Jaundice—Epirubicin—sarcoma	8.9e-05	0.000547	CcSEcCtD
Cyclosporine—Stomatitis—Epirubicin—sarcoma	8.9e-05	0.000547	CcSEcCtD
Cyclosporine—Constipation—Etoposide—sarcoma	8.88e-05	0.000546	CcSEcCtD
Cyclosporine—Pain—Etoposide—sarcoma	8.88e-05	0.000546	CcSEcCtD
Cyclosporine—Urinary tract infection—Epirubicin—sarcoma	8.87e-05	0.000545	CcSEcCtD
Cyclosporine—Conjunctivitis—Epirubicin—sarcoma	8.87e-05	0.000545	CcSEcCtD
Cyclosporine—Dysuria—Doxorubicin—sarcoma	8.86e-05	0.000544	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Doxorubicin—sarcoma	8.8e-05	0.000541	CcSEcCtD
Cyclosporine—Diarrhoea—Vincristine—sarcoma	8.77e-05	0.000539	CcSEcCtD
Cyclosporine—Pollakiuria—Doxorubicin—sarcoma	8.75e-05	0.000538	CcSEcCtD
Cyclosporine—Haematuria—Epirubicin—sarcoma	8.7e-05	0.000535	CcSEcCtD
Cyclosporine—ABCB1—lymphoid tissue—sarcoma	8.7e-05	0.000931	CbGeAlD
Cyclosporine—Hepatobiliary disease—Epirubicin—sarcoma	8.63e-05	0.00053	CcSEcCtD
Cyclosporine—Weight increased—Doxorubicin—sarcoma	8.62e-05	0.00053	CcSEcCtD
Cyclosporine—Epistaxis—Epirubicin—sarcoma	8.61e-05	0.000529	CcSEcCtD
Cyclosporine—Nausea—Thiotepa—sarcoma	8.59e-05	0.000528	CcSEcCtD
Cyclosporine—Weight decreased—Doxorubicin—sarcoma	8.57e-05	0.000527	CcSEcCtD
Cyclosporine—Sinusitis—Epirubicin—sarcoma	8.56e-05	0.000526	CcSEcCtD
Cyclosporine—Feeling abnormal—Etoposide—sarcoma	8.56e-05	0.000526	CcSEcCtD
Cyclosporine—Hyperglycaemia—Doxorubicin—sarcoma	8.54e-05	0.000525	CcSEcCtD
Cyclosporine—Diarrhoea—Mitoxantrone—sarcoma	8.54e-05	0.000525	CcSEcCtD
Cyclosporine—Nausea—Dactinomycin—sarcoma	8.52e-05	0.000524	CcSEcCtD
Cyclosporine—Pneumonia—Doxorubicin—sarcoma	8.49e-05	0.000522	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Etoposide—sarcoma	8.49e-05	0.000522	CcSEcCtD
Cyclosporine—Dizziness—Vincristine—sarcoma	8.48e-05	0.000521	CcSEcCtD
Cyclosporine—Infestation NOS—Doxorubicin—sarcoma	8.45e-05	0.000519	CcSEcCtD
Cyclosporine—Infestation—Doxorubicin—sarcoma	8.45e-05	0.000519	CcSEcCtD
Cyclosporine—Renal failure—Doxorubicin—sarcoma	8.3e-05	0.00051	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Doxorubicin—sarcoma	8.28e-05	0.000509	CcSEcCtD
Cyclosporine—Urticaria—Etoposide—sarcoma	8.25e-05	0.000507	CcSEcCtD
Cyclosporine—Haemoglobin—Epirubicin—sarcoma	8.24e-05	0.000506	CcSEcCtD
Cyclosporine—Jaundice—Doxorubicin—sarcoma	8.23e-05	0.000506	CcSEcCtD
Cyclosporine—Stomatitis—Doxorubicin—sarcoma	8.23e-05	0.000506	CcSEcCtD
Cyclosporine—Rhinitis—Epirubicin—sarcoma	8.21e-05	0.000505	CcSEcCtD
Cyclosporine—Abdominal pain—Etoposide—sarcoma	8.21e-05	0.000504	CcSEcCtD
Cyclosporine—Body temperature increased—Etoposide—sarcoma	8.21e-05	0.000504	CcSEcCtD
Cyclosporine—Urinary tract infection—Doxorubicin—sarcoma	8.21e-05	0.000504	CcSEcCtD
Cyclosporine—Conjunctivitis—Doxorubicin—sarcoma	8.21e-05	0.000504	CcSEcCtD
Cyclosporine—Haemorrhage—Epirubicin—sarcoma	8.19e-05	0.000503	CcSEcCtD
Cyclosporine—Hepatitis—Epirubicin—sarcoma	8.19e-05	0.000503	CcSEcCtD
Cyclosporine—Hypoaesthesia—Epirubicin—sarcoma	8.15e-05	0.000501	CcSEcCtD
Cyclosporine—Vomiting—Vincristine—sarcoma	8.15e-05	0.000501	CcSEcCtD
Cyclosporine—Pharyngitis—Epirubicin—sarcoma	8.13e-05	0.0005	CcSEcCtD
Cyclosporine—Urinary tract disorder—Epirubicin—sarcoma	8.09e-05	0.000497	CcSEcCtD
Cyclosporine—Rash—Vincristine—sarcoma	8.08e-05	0.000497	CcSEcCtD
Cyclosporine—Dermatitis—Vincristine—sarcoma	8.08e-05	0.000496	CcSEcCtD
Cyclosporine—Haematuria—Doxorubicin—sarcoma	8.05e-05	0.000495	CcSEcCtD
Cyclosporine—Connective tissue disorder—Epirubicin—sarcoma	8.05e-05	0.000495	CcSEcCtD
Cyclosporine—Urethral disorder—Epirubicin—sarcoma	8.03e-05	0.000494	CcSEcCtD
Cyclosporine—Headache—Vincristine—sarcoma	8.03e-05	0.000493	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Doxorubicin—sarcoma	7.99e-05	0.000491	CcSEcCtD
Cyclosporine—Epistaxis—Doxorubicin—sarcoma	7.97e-05	0.000489	CcSEcCtD
Cyclosporine—Vomiting—Mitoxantrone—sarcoma	7.94e-05	0.000488	CcSEcCtD
Cyclosporine—ABCB1—bone marrow—sarcoma	7.92e-05	0.000848	CbGeAlD
Cyclosporine—Sinusitis—Doxorubicin—sarcoma	7.92e-05	0.000487	CcSEcCtD
Cyclosporine—Visual impairment—Epirubicin—sarcoma	7.9e-05	0.000485	CcSEcCtD
Cyclosporine—Rash—Mitoxantrone—sarcoma	7.87e-05	0.000484	CcSEcCtD
Cyclosporine—Dermatitis—Mitoxantrone—sarcoma	7.86e-05	0.000483	CcSEcCtD
Cyclosporine—Headache—Mitoxantrone—sarcoma	7.82e-05	0.000481	CcSEcCtD
Cyclosporine—Hypersensitivity—Etoposide—sarcoma	7.65e-05	0.00047	CcSEcCtD
Cyclosporine—Tinnitus—Epirubicin—sarcoma	7.64e-05	0.000469	CcSEcCtD
Cyclosporine—Haemoglobin—Doxorubicin—sarcoma	7.62e-05	0.000468	CcSEcCtD
Cyclosporine—Nausea—Vincristine—sarcoma	7.61e-05	0.000468	CcSEcCtD
Cyclosporine—Flushing—Epirubicin—sarcoma	7.6e-05	0.000467	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—sarcoma	7.6e-05	0.000467	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—sarcoma	7.58e-05	0.000466	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—sarcoma	7.58e-05	0.000466	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—sarcoma	7.54e-05	0.000464	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—sarcoma	7.52e-05	0.000462	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—sarcoma	7.49e-05	0.00046	CcSEcCtD
Cyclosporine—Asthenia—Etoposide—sarcoma	7.45e-05	0.000458	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—sarcoma	7.45e-05	0.000458	CcSEcCtD
Cyclosporine—Angiopathy—Epirubicin—sarcoma	7.43e-05	0.000457	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—sarcoma	7.43e-05	0.000457	CcSEcCtD
Cyclosporine—Nausea—Mitoxantrone—sarcoma	7.42e-05	0.000456	CcSEcCtD
Cyclosporine—Mediastinal disorder—Epirubicin—sarcoma	7.38e-05	0.000454	CcSEcCtD
Cyclosporine—Chills—Epirubicin—sarcoma	7.35e-05	0.000452	CcSEcCtD
Cyclosporine—Pruritus—Etoposide—sarcoma	7.35e-05	0.000451	CcSEcCtD
Cyclosporine—Arrhythmia—Epirubicin—sarcoma	7.32e-05	0.00045	CcSEcCtD
Cyclosporine—Visual impairment—Doxorubicin—sarcoma	7.31e-05	0.000449	CcSEcCtD
Cyclosporine—Alopecia—Epirubicin—sarcoma	7.24e-05	0.000445	CcSEcCtD
Cyclosporine—Mental disorder—Epirubicin—sarcoma	7.18e-05	0.000441	CcSEcCtD
Cyclosporine—Malnutrition—Epirubicin—sarcoma	7.13e-05	0.000438	CcSEcCtD
Cyclosporine—Diarrhoea—Etoposide—sarcoma	7.11e-05	0.000437	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—sarcoma	7.07e-05	0.000434	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—sarcoma	7.04e-05	0.000432	CcSEcCtD
Cyclosporine—Flatulence—Epirubicin—sarcoma	7.03e-05	0.000432	CcSEcCtD
Cyclosporine—Tension—Epirubicin—sarcoma	7e-05	0.00043	CcSEcCtD
Cyclosporine—Dysgeusia—Epirubicin—sarcoma	6.98e-05	0.000429	CcSEcCtD
Cyclosporine—Nervousness—Epirubicin—sarcoma	6.93e-05	0.000426	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—sarcoma	6.88e-05	0.000423	CcSEcCtD
Cyclosporine—Dizziness—Etoposide—sarcoma	6.87e-05	0.000422	CcSEcCtD
Cyclosporine—Muscle spasms—Epirubicin—sarcoma	6.86e-05	0.000421	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—sarcoma	6.83e-05	0.00042	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—sarcoma	6.8e-05	0.000418	CcSEcCtD
Cyclosporine—ABCB1—testis—sarcoma	6.77e-05	0.000725	CbGeAlD
Cyclosporine—Arrhythmia—Doxorubicin—sarcoma	6.77e-05	0.000416	CcSEcCtD
Cyclosporine—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	6.76e-05	0.000962	CbGpPWpGaD
Cyclosporine—Vision blurred—Epirubicin—sarcoma	6.72e-05	0.000413	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—sarcoma	6.7e-05	0.000412	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by WNT in cancer—CTNNB1—sarcoma	6.68e-05	0.00095	CbGpPWpGaD
Cyclosporine—Mental disorder—Doxorubicin—sarcoma	6.64e-05	0.000408	CcSEcCtD
Cyclosporine—Ill-defined disorder—Epirubicin—sarcoma	6.62e-05	0.000407	CcSEcCtD
Cyclosporine—Vomiting—Etoposide—sarcoma	6.6e-05	0.000406	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—sarcoma	6.6e-05	0.000406	CcSEcCtD
Cyclosporine—Anaemia—Epirubicin—sarcoma	6.59e-05	0.000405	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—FOXO1—sarcoma	6.58e-05	0.000937	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—PDGFRB—sarcoma	6.57e-05	0.000936	CbGpPWpGaD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—KRAS—sarcoma	6.57e-05	0.000935	CbGpPWpGaD
Cyclosporine—Agitation—Epirubicin—sarcoma	6.55e-05	0.000403	CcSEcCtD
Cyclosporine—Rash—Etoposide—sarcoma	6.55e-05	0.000402	CcSEcCtD
Cyclosporine—Dermatitis—Etoposide—sarcoma	6.54e-05	0.000402	CcSEcCtD
Cyclosporine—Headache—Etoposide—sarcoma	6.51e-05	0.0004	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—sarcoma	6.5e-05	0.0004	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—sarcoma	6.48e-05	0.000398	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—PDGFRA—sarcoma	6.47e-05	0.000921	CbGpPWpGaD
Cyclosporine—Dysgeusia—Doxorubicin—sarcoma	6.46e-05	0.000397	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	6.46e-05	0.00092	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	6.45e-05	0.000918	CbGpPWpGaD
Cyclosporine—Malaise—Epirubicin—sarcoma	6.43e-05	0.000395	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—sarcoma	6.41e-05	0.000394	CcSEcCtD
Cyclosporine—Vertigo—Epirubicin—sarcoma	6.41e-05	0.000394	CcSEcCtD
Cyclosporine—ABCB1—liver—sarcoma	6.4e-05	0.000685	CbGeAlD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	6.4e-05	0.000911	CbGpPWpGaD
Cyclosporine—Leukopenia—Epirubicin—sarcoma	6.38e-05	0.000392	CcSEcCtD
Cyclosporine—Muscle spasms—Doxorubicin—sarcoma	6.35e-05	0.00039	CcSEcCtD
Cyclosporine—FKBP1A—Spinal Cord Injury—TP53—sarcoma	6.26e-05	0.000891	CbGpPWpGaD
Cyclosporine—Cough—Epirubicin—sarcoma	6.22e-05	0.000382	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—sarcoma	6.22e-05	0.000382	CcSEcCtD
Cyclosporine—Convulsion—Epirubicin—sarcoma	6.18e-05	0.00038	CcSEcCtD
Cyclosporine—Nausea—Etoposide—sarcoma	6.17e-05	0.000379	CcSEcCtD
Cyclosporine—Hypertension—Epirubicin—sarcoma	6.16e-05	0.000378	CcSEcCtD
Cyclosporine—Ill-defined disorder—Doxorubicin—sarcoma	6.12e-05	0.000376	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—sarcoma	6.1e-05	0.000375	CcSEcCtD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—TP53—sarcoma	6.08e-05	0.000866	CbGpPWpGaD
Cyclosporine—Myalgia—Epirubicin—sarcoma	6.07e-05	0.000373	CcSEcCtD
Cyclosporine—Arthralgia—Epirubicin—sarcoma	6.07e-05	0.000373	CcSEcCtD
Cyclosporine—Chest pain—Epirubicin—sarcoma	6.07e-05	0.000373	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—sarcoma	6.06e-05	0.000373	CcSEcCtD
Cyclosporine—Anxiety—Epirubicin—sarcoma	6.05e-05	0.000372	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	6.03e-05	0.000371	CcSEcCtD
Cyclosporine—PPIA—Disease—PLCG1—sarcoma	6e-05	0.000855	CbGpPWpGaD
Cyclosporine—Discomfort—Epirubicin—sarcoma	6e-05	0.000369	CcSEcCtD
Cyclosporine—ABCB1—Allograft Rejection—PDGFRA—sarcoma	5.96e-05	0.000849	CbGpPWpGaD
Cyclosporine—Malaise—Doxorubicin—sarcoma	5.95e-05	0.000366	CcSEcCtD
Cyclosporine—Dry mouth—Epirubicin—sarcoma	5.94e-05	0.000365	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—sarcoma	5.93e-05	0.000364	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—sarcoma	5.91e-05	0.000363	CcSEcCtD
Cyclosporine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	5.9e-05	0.000841	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—ENO2—sarcoma	5.88e-05	0.000837	CbGpPWpGaD
Cyclosporine—Confusional state—Epirubicin—sarcoma	5.87e-05	0.000361	CcSEcCtD
Cyclosporine—FKBP1A—Disease—TLE1—sarcoma	5.84e-05	0.000831	CbGpPWpGaD
Cyclosporine—PPP3CA—RNF mutants show enhanced WNT signaling and proliferation—MYC—sarcoma	5.82e-05	0.000829	CbGpPWpGaD
Cyclosporine—Anaphylactic shock—Epirubicin—sarcoma	5.82e-05	0.000358	CcSEcCtD
Cyclosporine—Oedema—Epirubicin—sarcoma	5.82e-05	0.000358	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	5.78e-05	0.000824	CbGpPWpGaD
Cyclosporine—Infection—Epirubicin—sarcoma	5.78e-05	0.000355	CcSEcCtD
Cyclosporine—SLC10A2—Metabolism—PLCG1—sarcoma	5.78e-05	0.000823	CbGpPWpGaD
Cyclosporine—PPIA—Disease—CXCR4—sarcoma	5.77e-05	0.000821	CbGpPWpGaD
Cyclosporine—Cough—Doxorubicin—sarcoma	5.76e-05	0.000354	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—sarcoma	5.72e-05	0.000351	CcSEcCtD
Cyclosporine—Nervous system disorder—Epirubicin—sarcoma	5.71e-05	0.000351	CcSEcCtD
Cyclosporine—Thrombocytopenia—Epirubicin—sarcoma	5.7e-05	0.00035	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—sarcoma	5.7e-05	0.00035	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—CXCR4—sarcoma	5.68e-05	0.000809	CbGpPWpGaD
Cyclosporine—Skin disorder—Epirubicin—sarcoma	5.65e-05	0.000347	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	5.63e-05	0.000802	CbGpPWpGaD
Cyclosporine—Hyperhidrosis—Epirubicin—sarcoma	5.63e-05	0.000346	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—sarcoma	5.62e-05	0.000345	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—sarcoma	5.62e-05	0.000345	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—sarcoma	5.62e-05	0.000345	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—sarcoma	5.6e-05	0.000344	CcSEcCtD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	5.58e-05	0.000794	CbGpPWpGaD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	5.58e-05	0.000343	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—sarcoma	5.55e-05	0.000341	CcSEcCtD
Cyclosporine—Anorexia—Epirubicin—sarcoma	5.55e-05	0.000341	CcSEcCtD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	5.54e-05	0.000789	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—PTPRC—sarcoma	5.52e-05	0.000786	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by Wnt—CTNNB1—sarcoma	5.5e-05	0.000784	CbGpPWpGaD
Cyclosporine—Dry mouth—Doxorubicin—sarcoma	5.5e-05	0.000338	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—sarcoma	5.43e-05	0.000334	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by WNT in cancer—MYC—sarcoma	5.41e-05	0.00077	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—PLCG1—sarcoma	5.4e-05	0.000769	CbGpPWpGaD
Cyclosporine—Anaphylactic shock—Doxorubicin—sarcoma	5.39e-05	0.000331	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—sarcoma	5.39e-05	0.000331	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—sarcoma	5.35e-05	0.000329	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Epirubicin—sarcoma	5.3e-05	0.000326	CcSEcCtD
Cyclosporine—Nervous system disorder—Doxorubicin—sarcoma	5.28e-05	0.000325	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—sarcoma	5.27e-05	0.000324	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—TLE1—sarcoma	5.27e-05	0.00075	CbGpPWpGaD
Cyclosporine—Insomnia—Epirubicin—sarcoma	5.27e-05	0.000324	CcSEcCtD
Cyclosporine—FKBP1A—Disease—NPM1—sarcoma	5.26e-05	0.000749	CbGpPWpGaD
Cyclosporine—Skin disorder—Doxorubicin—sarcoma	5.23e-05	0.000321	CcSEcCtD
Cyclosporine—Paraesthesia—Epirubicin—sarcoma	5.23e-05	0.000321	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—sarcoma	5.21e-05	0.00032	CcSEcCtD
Cyclosporine—Dyspnoea—Epirubicin—sarcoma	5.19e-05	0.000319	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	5.18e-05	0.000738	CbGpPWpGaD
Cyclosporine—Somnolence—Epirubicin—sarcoma	5.18e-05	0.000318	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—ATF1—sarcoma	5.13e-05	0.000731	CbGpPWpGaD
Cyclosporine—Anorexia—Doxorubicin—sarcoma	5.13e-05	0.000315	CcSEcCtD
Cyclosporine—Dyspepsia—Epirubicin—sarcoma	5.12e-05	0.000315	CcSEcCtD
Cyclosporine—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	5.08e-05	0.000723	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	5.07e-05	0.000722	CbGpPWpGaD
Cyclosporine—Decreased appetite—Epirubicin—sarcoma	5.06e-05	0.000311	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Epirubicin—sarcoma	5.03e-05	0.000309	CcSEcCtD
Cyclosporine—Fatigue—Epirubicin—sarcoma	5.02e-05	0.000308	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—KIT—sarcoma	5.02e-05	0.000714	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—PLCG1—sarcoma	4.99e-05	0.00071	CbGpPWpGaD
Cyclosporine—Pain—Epirubicin—sarcoma	4.98e-05	0.000306	CcSEcCtD
Cyclosporine—Constipation—Epirubicin—sarcoma	4.98e-05	0.000306	CcSEcCtD
Cyclosporine—ABCB1—lymph node—sarcoma	4.91e-05	0.000525	CbGeAlD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—sarcoma	4.91e-05	0.000302	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—sarcoma	4.87e-05	0.000299	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—sarcoma	4.84e-05	0.000297	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—sarcoma	4.8e-05	0.000295	CcSEcCtD
Cyclosporine—Feeling abnormal—Epirubicin—sarcoma	4.8e-05	0.000295	CcSEcCtD
Cyclosporine—PPP3CA—Disease—CXCR4—sarcoma	4.79e-05	0.000683	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	4.79e-05	0.000682	CbGpPWpGaD
Cyclosporine—Somnolence—Doxorubicin—sarcoma	4.79e-05	0.000294	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—CREB1—sarcoma	4.78e-05	0.00068	CbGpPWpGaD
Cyclosporine—Gastrointestinal pain—Epirubicin—sarcoma	4.76e-05	0.000293	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—sarcoma	4.74e-05	0.000291	CcSEcCtD
Cyclosporine—PPIA—Hemostasis—IL2—sarcoma	4.72e-05	0.000672	CbGpPWpGaD
Cyclosporine—Decreased appetite—Doxorubicin—sarcoma	4.68e-05	0.000288	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—sarcoma	4.65e-05	0.000286	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—sarcoma	4.64e-05	0.000285	CcSEcCtD
Cyclosporine—Urticaria—Epirubicin—sarcoma	4.62e-05	0.000284	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—sarcoma	4.61e-05	0.000283	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—sarcoma	4.61e-05	0.000283	CcSEcCtD
Cyclosporine—Body temperature increased—Epirubicin—sarcoma	4.6e-05	0.000283	CcSEcCtD
Cyclosporine—Abdominal pain—Epirubicin—sarcoma	4.6e-05	0.000283	CcSEcCtD
Cyclosporine—FKBP1A—Disease—ENO2—sarcoma	4.56e-05	0.000649	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by Wnt—MYC—sarcoma	4.46e-05	0.000635	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—VEGFC—sarcoma	4.45e-05	0.000633	CbGpPWpGaD
Cyclosporine—Feeling abnormal—Doxorubicin—sarcoma	4.44e-05	0.000273	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—sarcoma	4.4e-05	0.000271	CcSEcCtD
Cyclosporine—SLC10A1—Metabolism—ENO2—sarcoma	4.39e-05	0.000625	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—HBA1—sarcoma	4.36e-05	0.000621	CbGpPWpGaD
Cyclosporine—Hypersensitivity—Epirubicin—sarcoma	4.29e-05	0.000264	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—sarcoma	4.28e-05	0.000263	CcSEcCtD
Cyclosporine—PPIA—Disease—FOXO1—sarcoma	4.26e-05	0.000607	CbGpPWpGaD
Cyclosporine—Body temperature increased—Doxorubicin—sarcoma	4.26e-05	0.000262	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—sarcoma	4.26e-05	0.000262	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	4.26e-05	0.000606	CbGpPWpGaD
Cyclosporine—PPIA—Disease—PDGFRB—sarcoma	4.25e-05	0.000605	CbGpPWpGaD
Cyclosporine—PPIA—Disease—PDGFRA—sarcoma	4.19e-05	0.000596	CbGpPWpGaD
Cyclosporine—Asthenia—Epirubicin—sarcoma	4.18e-05	0.000257	CcSEcCtD
Cyclosporine—Pruritus—Epirubicin—sarcoma	4.12e-05	0.000253	CcSEcCtD
Cyclosporine—PPIA—Hemostasis—SRC—sarcoma	4.12e-05	0.000586	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TLE1—sarcoma	4.09e-05	0.000582	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—VEGFA—sarcoma	4.01e-05	0.000571	CbGpPWpGaD
Cyclosporine—Diarrhoea—Epirubicin—sarcoma	3.98e-05	0.000245	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—sarcoma	3.97e-05	0.000244	CcSEcCtD
Cyclosporine—PPIA—Hemostasis—NRAS—sarcoma	3.96e-05	0.000564	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—MDM2—sarcoma	3.95e-05	0.000563	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PLCG1—sarcoma	3.87e-05	0.000551	CbGpPWpGaD
Cyclosporine—Asthenia—Doxorubicin—sarcoma	3.86e-05	0.000237	CcSEcCtD
Cyclosporine—Dizziness—Epirubicin—sarcoma	3.85e-05	0.000237	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—FOXO1—sarcoma	3.84e-05	0.000546	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—PDGFRB—sarcoma	3.83e-05	0.000545	CbGpPWpGaD
Cyclosporine—Pruritus—Doxorubicin—sarcoma	3.81e-05	0.000234	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—PDGFRA—sarcoma	3.77e-05	0.000537	CbGpPWpGaD
Cyclosporine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	3.73e-05	0.000531	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PLCG1—sarcoma	3.72e-05	0.00053	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CXCR4—sarcoma	3.72e-05	0.000529	CbGpPWpGaD
Cyclosporine—Vomiting—Epirubicin—sarcoma	3.7e-05	0.000227	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—sarcoma	3.69e-05	0.000226	CcSEcCtD
Cyclosporine—Rash—Epirubicin—sarcoma	3.67e-05	0.000226	CcSEcCtD
Cyclosporine—Dermatitis—Epirubicin—sarcoma	3.67e-05	0.000225	CcSEcCtD
Cyclosporine—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	3.65e-05	0.00052	CbGpPWpGaD
Cyclosporine—Headache—Epirubicin—sarcoma	3.65e-05	0.000224	CcSEcCtD
Cyclosporine—Dizziness—Doxorubicin—sarcoma	3.56e-05	0.000219	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—FLT1—sarcoma	3.56e-05	0.000506	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—FOXO1—sarcoma	3.54e-05	0.000504	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—PDGFRB—sarcoma	3.53e-05	0.000503	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PLCG1—sarcoma	3.49e-05	0.000497	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—PDGFRA—sarcoma	3.48e-05	0.000495	CbGpPWpGaD
Cyclosporine—Nausea—Epirubicin—sarcoma	3.46e-05	0.000212	CcSEcCtD
Cyclosporine—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	3.46e-05	0.000492	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—VEGFC—sarcoma	3.45e-05	0.000491	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—JUN—sarcoma	3.43e-05	0.000489	CbGpPWpGaD
Cyclosporine—Vomiting—Doxorubicin—sarcoma	3.42e-05	0.00021	CcSEcCtD
Cyclosporine—PPIA—Hemostasis—KRAS—sarcoma	3.41e-05	0.000485	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—CTNNB1—sarcoma	3.41e-05	0.000485	CbGpPWpGaD
Cyclosporine—Rash—Doxorubicin—sarcoma	3.4e-05	0.000209	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—sarcoma	3.39e-05	0.000208	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—sarcoma	3.37e-05	0.000207	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—CXCR4—sarcoma	3.36e-05	0.000478	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—ATF1—sarcoma	3.32e-05	0.000473	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—IL2—sarcoma	3.25e-05	0.000463	CbGpPWpGaD
Cyclosporine—PPIA—Disease—KIT—sarcoma	3.25e-05	0.000462	CbGpPWpGaD
Cyclosporine—Nausea—Doxorubicin—sarcoma	3.2e-05	0.000197	CcSEcCtD
Cyclosporine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	3.19e-05	0.000454	CbGpPWpGaD
Cyclosporine—PPIA—Disease—CREB1—sarcoma	3.09e-05	0.00044	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—SRC—sarcoma	3.08e-05	0.000439	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CREB1—sarcoma	3.04e-05	0.000433	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—TP53—sarcoma	3.03e-05	0.000431	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—TLE1—sarcoma	2.97e-05	0.000423	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—NRAS—sarcoma	2.96e-05	0.000422	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	2.94e-05	0.000419	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—KIT—sarcoma	2.92e-05	0.000416	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—HRAS—sarcoma	2.9e-05	0.000413	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CREB1—sarcoma	2.78e-05	0.000396	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—VEGFA—sarcoma	2.76e-05	0.000394	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—FLT1—sarcoma	2.76e-05	0.000392	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—FOXO1—sarcoma	2.75e-05	0.000391	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PDGFRB—sarcoma	2.74e-05	0.00039	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PLCG1—sarcoma	2.71e-05	0.000386	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—EGFR—sarcoma	2.7e-05	0.000384	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PDGFRA—sarcoma	2.7e-05	0.000384	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—KIT—sarcoma	2.7e-05	0.000384	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NPM1—sarcoma	2.68e-05	0.000381	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IGF1R—sarcoma	2.61e-05	0.000371	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCR4—sarcoma	2.6e-05	0.000371	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—ENO2—sarcoma	2.59e-05	0.000368	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—ATF1—sarcoma	2.57e-05	0.000366	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—HBA1—sarcoma	2.57e-05	0.000366	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CREB1—sarcoma	2.57e-05	0.000366	CbGpPWpGaD
Cyclosporine—PPIA—Disease—MDM2—sarcoma	2.56e-05	0.000364	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—KRAS—sarcoma	2.55e-05	0.000363	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—ENO2—sarcoma	2.48e-05	0.000353	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—FOXO1—sarcoma	2.48e-05	0.000353	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PDGFRB—sarcoma	2.48e-05	0.000352	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—HBA1—sarcoma	2.47e-05	0.000351	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PDGFRA—sarcoma	2.44e-05	0.000347	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ENO2—sarcoma	2.32e-05	0.00033	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—MDM2—sarcoma	2.3e-05	0.000328	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—IL2—sarcoma	2.25e-05	0.00032	CbGpPWpGaD
Cyclosporine—PPIA—Disease—CTNNB1—sarcoma	2.21e-05	0.000314	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PLCG1—sarcoma	2.2e-05	0.000313	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.17e-05	0.000309	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—HRAS—sarcoma	2.17e-05	0.000309	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ENO2—sarcoma	2.16e-05	0.000308	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—HBA1—sarcoma	2.15e-05	0.000306	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—MDM2—sarcoma	2.12e-05	0.000303	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PLCG1—sarcoma	2.1e-05	0.0003	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KIT—sarcoma	2.09e-05	0.000298	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL2—sarcoma	2.06e-05	0.000293	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KDR—sarcoma	2.05e-05	0.000292	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IGF1R—sarcoma	2.02e-05	0.000288	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—JUN—sarcoma	2e-05	0.000285	CbGpPWpGaD
Cyclosporine—PPIA—Disease—SRC—sarcoma	1.99e-05	0.000284	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CREB1—sarcoma	1.99e-05	0.000283	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CTNNB1—sarcoma	1.99e-05	0.000283	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PLCG1—sarcoma	1.97e-05	0.00028	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ENO2—sarcoma	1.94e-05	0.000277	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—HBA1—sarcoma	1.93e-05	0.000275	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—FOXO1—sarcoma	1.92e-05	0.000274	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PDGFRB—sarcoma	1.92e-05	0.000273	CbGpPWpGaD
Cyclosporine—PPIA—Disease—NRAS—sarcoma	1.92e-05	0.000273	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CXCR4—sarcoma	1.89e-05	0.000269	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KIT—sarcoma	1.89e-05	0.000269	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PDGFRA—sarcoma	1.89e-05	0.000269	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—NRAS—sarcoma	1.89e-05	0.000269	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ENO2—sarcoma	1.85e-05	0.000263	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—HBA1—sarcoma	1.84e-05	0.000261	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CTNNB1—sarcoma	1.83e-05	0.000261	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PLCG1—sarcoma	1.83e-05	0.000261	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CREB1—sarcoma	1.8e-05	0.000256	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.8e-05	0.000256	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—SRC—sarcoma	1.79e-05	0.000255	CbGpPWpGaD
Cyclosporine—PPIA—Disease—MYC—sarcoma	1.79e-05	0.000254	CbGpPWpGaD
Cyclosporine—PPIA—Disease—EGFR—sarcoma	1.75e-05	0.000249	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—NRAS—sarcoma	1.73e-05	0.000246	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—EGFR—sarcoma	1.72e-05	0.000245	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ENO2—sarcoma	1.71e-05	0.000243	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—HBA1—sarcoma	1.7e-05	0.000242	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ENO2—sarcoma	1.7e-05	0.000241	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—HBA1—sarcoma	1.68e-05	0.00024	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—SRC—sarcoma	1.66e-05	0.000236	CbGpPWpGaD
Cyclosporine—PPIA—Disease—KRAS—sarcoma	1.65e-05	0.000235	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PLCG1—sarcoma	1.65e-05	0.000235	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MDM2—sarcoma	1.65e-05	0.000235	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—KRAS—sarcoma	1.63e-05	0.000231	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—NRAS—sarcoma	1.59e-05	0.000227	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KDR—sarcoma	1.59e-05	0.000226	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—EGFR—sarcoma	1.57e-05	0.000224	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PLCG1—sarcoma	1.57e-05	0.000223	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.56e-05	0.000223	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.56e-05	0.000222	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.55e-05	0.000221	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MDM2—sarcoma	1.49e-05	0.000212	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—KRAS—sarcoma	1.49e-05	0.000212	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—MYC—sarcoma	1.48e-05	0.000211	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KIT—sarcoma	1.46e-05	0.000209	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—EGFR—sarcoma	1.45e-05	0.000207	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PLCG1—sarcoma	1.45e-05	0.000207	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PLCG1—sarcoma	1.44e-05	0.000205	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CTNNB1—sarcoma	1.42e-05	0.000202	CbGpPWpGaD
Cyclosporine—PPIA—Disease—HRAS—sarcoma	1.4e-05	0.0002	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.4e-05	0.000199	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—FOXO1—sarcoma	1.4e-05	0.000199	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PDGFRB—sarcoma	1.39e-05	0.000199	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CREB1—sarcoma	1.39e-05	0.000199	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—HRAS—sarcoma	1.38e-05	0.000197	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PDGFRA—sarcoma	1.37e-05	0.000195	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—KRAS—sarcoma	1.37e-05	0.000195	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.36e-05	0.000194	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL2—sarcoma	1.33e-05	0.000189	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCND1—sarcoma	1.3e-05	0.000185	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—JUN—sarcoma	1.29e-05	0.000184	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—SRC—sarcoma	1.28e-05	0.000183	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CTNNB1—sarcoma	1.28e-05	0.000183	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HRAS—sarcoma	1.26e-05	0.00018	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.26e-05	0.000179	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—NRAS—sarcoma	1.24e-05	0.000176	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.23e-05	0.000175	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ENO2—sarcoma	1.23e-05	0.000174	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—HBA1—sarcoma	1.22e-05	0.000173	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—HRAS—sarcoma	1.17e-05	0.000166	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—SRC—sarcoma	1.16e-05	0.000165	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.16e-05	0.000165	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MDM2—sarcoma	1.15e-05	0.000164	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MYC—sarcoma	1.15e-05	0.000164	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—VEGFA—sarcoma	1.13e-05	0.000161	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—EGFR—sarcoma	1.13e-05	0.00016	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—NRAS—sarcoma	1.12e-05	0.000159	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KIT—sarcoma	1.06e-05	0.000152	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KRAS—sarcoma	1.06e-05	0.000151	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ENO2—sarcoma	1.06e-05	0.000151	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—HBA1—sarcoma	1.05e-05	0.00015	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PLCG1—sarcoma	1.04e-05	0.000148	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MYC—sarcoma	1.04e-05	0.000148	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL2—sarcoma	1.03e-05	0.000147	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.03e-05	0.000147	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EGFR—sarcoma	1.02e-05	0.000145	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CREB1—sarcoma	1.01e-05	0.000144	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCND1—sarcoma	1e-05	0.000143	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—JUN—sarcoma	1e-05	0.000143	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CTNNB1—sarcoma	9.95e-06	0.000142	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KRAS—sarcoma	9.61e-06	0.000137	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ENO2—sarcoma	9.47e-06	0.000135	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—HBA1—sarcoma	9.41e-06	0.000134	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ENO2—sarcoma	9.25e-06	0.000132	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—HBA1—sarcoma	9.19e-06	0.000131	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HRAS—sarcoma	9.04e-06	0.000129	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PLCG1—sarcoma	9.01e-06	0.000128	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—SRC—sarcoma	9e-06	0.000128	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—VEGFA—sarcoma	8.76e-06	0.000125	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ENO2—sarcoma	8.71e-06	0.000124	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—HBA1—sarcoma	8.66e-06	0.000123	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NRAS—sarcoma	8.65e-06	0.000123	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ENO2—sarcoma	8.64e-06	0.000123	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—HBA1—sarcoma	8.58e-06	0.000122	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—sarcoma	8.54e-06	0.000122	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MDM2—sarcoma	8.39e-06	0.000119	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—HRAS—sarcoma	8.17e-06	0.000116	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—sarcoma	8.06e-06	0.000115	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PLCG1—sarcoma	8.04e-06	0.000114	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EGFR—sarcoma	7.88e-06	0.000112	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PLCG1—sarcoma	7.85e-06	0.000112	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—sarcoma	7.45e-06	0.000106	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PLCG1—sarcoma	7.39e-06	0.000105	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PLCG1—sarcoma	7.33e-06	0.000104	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CTNNB1—sarcoma	7.23e-06	0.000103	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—sarcoma	6.62e-06	9.42e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SRC—sarcoma	6.54e-06	9.31e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—sarcoma	6.33e-06	9.01e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NRAS—sarcoma	6.29e-06	8.95e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—sarcoma	5.86e-06	8.34e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGFR—sarcoma	5.73e-06	8.16e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ENO2—sarcoma	5.7e-06	8.11e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HBA1—sarcoma	5.66e-06	8.06e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—sarcoma	5.41e-06	7.71e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PLCG1—sarcoma	4.83e-06	6.88e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—sarcoma	4.6e-06	6.55e-05	CbGpPWpGaD
